Account
ITW Playworx co has Sachin’s Billion Dreams mandate, releasing today
MUMBAI: Matchbox Media, a media arm of ITW Playworx bagged the overseas media duties of Sachin: A Billion Dreams, the top starrer and much awaited Indian biographical film. The movie directed by James Erskine and produced by Ravi Bhagchandka Carnival Motion Pictures, starring Sachin Tendulkar, Virendra Sehwag, Mayuresh Pem amongst others will hit the screens across the globe on 26 May 2017.
The mandate included TV media planning, buying and release in US, UK, Canada, Europe, Middle East, Africa and Asia Pacific Region. Since the movie captures the star’s cricket and personal life and also reveals few aspects of his life which have never been heard of or seen before, the agency’s first task was to design and implement a communication plan to ensure the movie touches minds of viewers across the globe.
Cinestaan AA Distributors MD and CEO Anil Thadani said, “Sachin: A Billion Dreams is the most-awaited film of the year and we are pleased to associate with Matchbox Media as our media agency. The whole idea was to tap the global markets considering the huge anticipation for the film and Matchbox Media team has successfully executed the same.”
Confirming the win, Sidharth Ghosh, CEO, ITW Playworx said, “We We are looking forward to make our presence stronger in the international markets considering the demand for Indian films across the globe.”
Dipesh Negi & Mohit Mishra, Founders, Matchbox Media said, “We are delighted that the makers and distributors of the film have instilled their confidence and given us the opportunity to work on this landmark film.”
The mandate was spread across channels like Times Now International, Sony International, Colors International, Star International, Zee International and B4U International.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
